| Product NDC: | 65162-641 |
| Proprietary Name: | Flecainide Acetate |
| Non Proprietary Name: | Flecainide Acetate |
| Active Ingredient(s): | 50 mg/1 & nbsp; Flecainide Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65162-641 |
| Labeler Name: | Amneal Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075442 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091201 |
| Package NDC: | 65162-641-11 |
| Package Description: | 1000 TABLET in 1 BOTTLE (65162-641-11) |
| NDC Code | 65162-641-11 |
| Proprietary Name | Flecainide Acetate |
| Package Description | 1000 TABLET in 1 BOTTLE (65162-641-11) |
| Product NDC | 65162-641 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Flecainide Acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20091201 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals, LLC |
| Substance Name | FLECAINIDE ACETATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |